Skip to main content
SpringerLink
Log in

Cyclosporine for Systemic Onset Juvenile Idiopathic Arthritis: Current Stand and Future Directions

  • Editorial Commentary
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Seth V, Kabra SK, Semwal OP, Jain Y. Clinico-immunological profile in juvenile rheumatoid arthritis--an Indian experience. Indian J Pediatr. 1996;63:293–300.

    Article  CAS  PubMed  Google Scholar 

  2. Sawhney S, Magalhães CS. Paediatric rheumatology—a global perspective. Best Pract Res Clin Rheumatol. 2006;20:201–21.

    Article  PubMed  Google Scholar 

  3. Ringold S, Weiss PF, Beukelman T, et al. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Care Res. 2013;65:1551–63.

    Article  Google Scholar 

  4. Chighizola CB, Ong VH, Meroni PL. The use of cyclosporine A in rheumatology: a 2016 comprehensive review. Clin Rev Allergy Immunol. 2017;52:401–23.

    Article  CAS  PubMed  Google Scholar 

  5. Grevich S, Shenoi S. Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition. Adolesc Health Med Ther. 2017;8:125–35.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Boom V, Anton J, Lahdenne P, et al. Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J [Internet]. 2015 Dec 3;13. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669611/. Accessed on 4 May 2019.

  7. Pal P, Giri PP, Sinha R. Cyclosporine in resistant systemic arthritis - a cheaper alternative to biologics. Indian J Pediatr. 2019. https://doi.org/10.1007/s12098-019-02912-9.

  8. Gerloni V, Cimaz R, Gattinara M, Arnoldi C, Pontikaki I, Fantini F. Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study. Rheumatol Oxf Engl. 2001;40:907–13.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Rheumatology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India

    Narendra Kumar Bagri

Authors
  1. Narendra Kumar Bagri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Narendra Kumar Bagri.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bagri, N.K. Cyclosporine for Systemic Onset Juvenile Idiopathic Arthritis: Current Stand and Future Directions. Indian J Pediatr 86, 576–577 (2019). https://doi.org/10.1007/s12098-019-02985-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-019-02985-6

Search

Navigation